GENEVA, Oct. 30 -- HUAWEI TECHNOLOGIES CO., LTD. filed a patent application (CN2026/092715) for “STYLUS INTERACTION METHOD AND SYSTEM, AND RELATED APPARATUS”. With publication no. WO/2026/223779, here... Read More
GENEVA, Oct. 30 -- ZHEJIANG DOER BIOLOGICS CO., LTD filed a patent application (CN2026/092720) for “AXL-TARGETING SINGLE-DOMAIN ANTIBODY, BISPECIFIC ANTIBODY, ANTIBODY-DRUG CONJUGATE, AND USE THEREOF”... Read More
GENEVA, Oct. 30 -- HELIXON BIOTECHNOLOGY (SUZHOU) CO., LTD filed a patent application (CN2026/092680) for “ANTIBODY-DRUG CONJUGATE TARGETING DLL3 AND USE THEREOF”. With publication no. WO/2026/223773,... Read More
GENEVA, Oct. 30 -- CCTEG COAL MINING RESEARCH INSTITUTE filed a patent application (CN2026/092685) for “ROOF DYNAMIC STRESS MONITORING SENSING DEVICE AND STRESS MONITORING METHOD”. With publication no... Read More
GENEVA, Oct. 30 -- HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD. filed a patent application (CN2026/092694) for “COMPOSITE STRUCTURE, GUIDE SHEATH AND PREPARATION METHOD FOR COMPOSITE STRUCTURE”. With pub... Read More
GENEVA, Oct. 30 -- HELIXON BIOTECHNOLOGY (SUZHOU) CO., LTD filed a patent application (CN2026/092674) for “ANTI-DLL3 ANTIBODY AND USE THEREOF”. With publication no. WO/2026/223770, here are the other ... Read More
GENEVA, Oct. 30 -- BEIJING HORIZON INFORMATION TECHNOLOGY CO., LTD. filed a patent application (CN2026/092678) for “IMAGE DISPLAY METHOD AND APPARATUS, AND STORAGE MEDIUM AND ELECTRONIC DEVICE”. With ... Read More
GENEVA, Oct. 30 -- HELIXON BIOTECHNOLOGY (SUZHOU) CO., LTD filed a patent application (CN2026/092679) for “MULTISPECIFIC ANTIBODY TARGETING TROP2 AND PD-L1, AND ANTIBODY-DRUG CONJUGATE THEREOF AND USE... Read More
GENEVA, Oct. 30 -- HELIXON BIOTECHNOLOGY (SUZHOU) CO., LTD filed a patent application (CN2026/092653) for “T CELL ENGAGER (TCE) TARGETING CEACAM5 AND CDH17, AND USE THEREOF”. With publication no. WO/2... Read More
GENEVA, Oct. 30 -- HELIXON BIOTECHNOLOGY (SUZHOU) CO., LTD filed a patent application (CN2026/092661) for “BIPARATOPIC ANTIBODY TARGETING CDH17, ANTIBODY-DRUG CONJUGATE, AND USE THEREOF”. With publica... Read More